Y-Intercept (HK)’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $877K | Buy |
+22,839
| New | +$877K | 0.02% | 997 |
|
|
2024
Q4 | – | Sell |
-53,078
| Closed | -$2.17M | – | 1373 |
|
|
2024
Q3 | $2.17M | Sell |
53,078
-15,977
| -23% | -$653K | 0.13% | 188 |
|
|
2024
Q2 | $2.66M | Buy |
+69,055
| New | +$2.66M | 0.15% | 175 |
|
|
2024
Q1 | – | Sell |
-43,888
| Closed | -$1.63M | – | 1520 |
|
|
2023
Q4 | $1.63M | Sell |
43,888
-31,038
| -41% | -$1.15M | 0.15% | 182 |
|
|
2023
Q3 | $2.72M | Buy |
74,926
+45,943
| +159% | +$1.67M | 0.27% | 84 |
|
|
2023
Q2 | $1.03M | Sell |
28,983
-60,007
| -67% | -$2.14M | 0.11% | 282 |
|
|
2023
Q1 | $3.17M | Buy |
88,990
+52,456
| +144% | +$1.87M | 0.37% | 33 |
|
|
2022
Q4 | $1.28M | Sell |
36,534
-48,071
| -57% | -$1.69M | 0.19% | 137 |
|
|
2022
Q3 | $2.49M | Buy |
+84,605
| New | +$2.49M | 0.25% | 104 |
|
|
2022
Q1 | – | Sell |
-22,110
| Closed | -$1.22M | – | 809 |
|
|
2021
Q4 | $1.22M | Buy |
+22,110
| New | +$1.22M | 0.29% | 85 |
|
|
2021
Q3 | – | Sell |
-17,006
| Closed | -$846K | – | 751 |
|
|
2021
Q2 | $846K | Buy |
+17,006
| New | +$846K | 0.22% | 130 |
|